News
Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will present at the World Vaccine Congress ...
It’s difficult to predict what this year’s flu season is going to be like. But it’s a good time to start thinking about ...
Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or ...
Many people aren’t benefiting from the shingles vaccine now. Not only can it prevent shingles — it also may protect the brain ...
Traditional vaccines are made by attenuating Bacillus anthracis or culturing non-pathogenic Bacillus anthracis, which may ...
New Cleveland Clinic research reveals vaccinated staff had higher flu infection rates, but experts caution about study ...
Whooping cough, or pertussis, was once a leading cause of death for children in the U.S. and worldwide before the ...
A study of over 280,000 adults found that the shingles vaccine reduced dementia risk by 20%, with a stronger effect in women.
There are several new flu vaccines currently under development. Recombinant vaccines, such as Flublok, use insect cells to produce a specific component of the virus. With the success of mRNA ...
New research could aid in improving whooping cough vaccines to once again push this disease toward eradication by targeting two key weaknesses in the infection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results